Cargando…

Prostatic-Like Syndrome in a Woman with Chronic Lymphocytic Leukemia: Sequential Kinase Inhibitor Therapy

Chronic lymphocytic leukemia (CLL) is an incurable lymphoproliferative disorder with a heterogeneous genetic and clinical course. Two kinase inhibitors, ibrutinib and idelalisib, have demonstrated achievement of complete and durable remissions in relapse/refractory genetically unselected CLL patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Velasco-Rodríguez, Diego, Piris-Villaespesa, Miguel, Soteras, Carmen, Vallés, Ana, García-Marco, José Antonio, García-Vela, José Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511649/ https://www.ncbi.nlm.nih.gov/pubmed/28751992 http://dx.doi.org/10.1155/2017/3869020

Ejemplares similares

Systemic Mastocytosis: Following the Tyrosine Kinase Inhibition Roadmap
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2020)

An Urologic Face of Chronic Lymphocytic Leukemia: Sequential Prostatic and Penis Localization
por: D’Arena, Giovanni, et al.
Publicado: (2013)

Development and validation of a sequential two-step algorithm for the screening of individuals with potential polycythaemia vera
por: Piris-Villaespesa, Miguel, et al.
Publicado: (2021)

Lymphoplasmacytic lymphoma and marginal zone lymphoma involving bone marrow: A diagnostic dilemma. Useful clinicopathological features to accurate the diagnosis
por: García‐Abellás, Patricia, et al.
Publicado: (2022)

Vascular Endothelial Growth Factor A (VEGFA) Gene Polymorphisms Have an Impact on Survival in a Subgroup of Indolent Patients with Chronic Lymphocytic Leukemia
por: Lozano-Santos, Carol, et al.
Publicado: (2014)

Small Lymphocytic Lymphoma/Chronic Lymphocytic Leukemia with Chromothripsis in an Old Woman
por: Tan, Li, et al.
Publicado: (2015)

Identification of Immunological Parameters as Predictive Biomarkers of Relapse in Patients with Chronic Myeloid Leukemia on Treatment-Free Remission
por: Vigón, Lorena, et al.
Publicado: (2020)

New Mutations in Chronic Lymphocytic Leukemia Identified by Target Enrichment and Deep Sequencing
por: Doménech, Elena, et al.
Publicado: (2012)

Sequential and combination treatments with novel agents in chronic lymphocytic leukemia
por: Fürstenau, Moritz, et al.
Publicado: (2019)

Pregnancy in a 31-year-old woman with chronic lymphocytic leukemia: a case report and review of the literature
por: Murray, Nigel P., et al.
Publicado: (2021)

Lymphocytes with auer rod-like inclusions in chronic lymphocytic leukemia
por: Roldán Galiacho, Verónica, et al.
Publicado: (2022)

Leukemia Cutis As the Initial Manifestation of Chronic Lymphocytic Leukemia Progression
por: Pedreira-García, Wilfredo M, et al.
Publicado: (2022)

Inhibitory Effects of Sigma-2 Receptor Agonists on T Lymphocyte Activation
por: Iñiguez, Miguel A., et al.
Publicado: (2013)

Radiotherapy for isolated granulocytic sarcoma: Case report and review of literature
por: Dominguez Rullán, Jose Antonio, et al.
Publicado: (2017)

Early detection of lysosomal diseases by screening of cases of idiopathic splenomegaly and/or thrombocytopenia with a next‐generation sequencing gene panel
por: Muñoz, Gloria, et al.
Publicado: (2019)

A Different View for an Old Disease: NEDDylation and Other Ubiquitin-Like Post-Translational Modifications in Chronic Lymphocytic Leukemia
por: Arenas, Víctor, et al.
Publicado: (2021)

Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic
por: Arellano-Llamas, Abril Adriana, et al.
Publicado: (2022)

IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia
por: Ruiz-Lafuente, Natalia, et al.
Publicado: (2015)

Effect of Lenalidomide Maintenance in Chronic Lymphocytic Leukemia: A Meta-Analysis and Trial-Sequential Analysis
por: Yu, Tsung-Ying, et al.
Publicado: (2022)

PB1873: EFFECTS OF LENALIDOMIDE MAINTENANCE IN CHRONIC LYMPHOCYTIC LEUKEMIA: A TRIAL-SEQUENTIAL ANALYSIS
por: Lee, C.-H., et al.
Publicado: (2022)

Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
por: Jiménez, Isabel, et al.
Publicado: (2021)

Proposal and validation of a method to classify genetic subtypes of diffuse large B cell lymphoma
por: Pedrosa, Lucía, et al.
Publicado: (2021)

Cytoplasmic crystal inclusions in lymphocytes of chronic lymphocytic leukemia
por: Villuendas Vázquez, Òscar, et al.
Publicado: (2020)

Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain
por: Galindo-Navarro, Pablo, et al.
Publicado: (2023)

Postpartum amaurosis in a woman with severe preeclampsia
por: Mourelo, Mónica, et al.
Publicado: (2011)

Various inclusions in chronic lymphocytic leukemia/small lymphocytic lymphoma
por: Galiacho, Verónica Roldán, et al.
Publicado: (2022)

Real-World Evidence on the Clinical Characteristics and Management of Patients with Chronic Lymphocytic Leukemia in Spain Using Natural Language Processing: The SRealCLL Study
por: Loscertales, Javier, et al.
Publicado: (2023)

Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations
por: Ruz-Caracuel, Ignacio, et al.
Publicado: (2022)

The Gene Expression Response of Chronic Lymphocytic Leukemia Cells to IL-4 Is Specific, Depends on ZAP-70 Status and Is Differentially Affected by an NFκB Inhibitor
por: Ruiz-Lafuente, Natalia, et al.
Publicado: (2014)

Lenalidomide and Chronic Lymphocytic Leukemia
por: González-Rodríguez, Ana Pilar, et al.
Publicado: (2013)

Identification of tipifarnib sensitivity biomarkers in T-cell acute lymphoblastic leukemia and T-cell lymphoma
por: Alonso-Alonso, Ruth, et al.
Publicado: (2020)

Long-Term Outcomes with Sequential Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia Patients
por: Towachiraporn, Saikhuan, et al.
Publicado: (2023)

Unravelling soluble immune checkpoints in chronic lymphocytic leukemia: Physiological immunomodulators or immune dysfunction
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2022)

Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia
por: Märklin, Melanie, et al.
Publicado: (2020)

The evolving role of Bruton’s tyrosine kinase inhibitors in chronic lymphocytic leukemia
por: Gordon, Max J., et al.
Publicado: (2021)

High Mitochondrial DNA Stability in B-Cell Chronic Lymphocytic Leukemia
por: Cerezo, María, et al.
Publicado: (2009)

Safety of COVID-19 vaccination in patients with clonal mast cell disorders
por: Ruano-Zaragoza, Maria, et al.
Publicado: (2022)

Map of ubiquitin-like post-translational modifications in chronic lymphocytic leukemia. Role of p53 lysine 120 NEDDylation
por: Bravo-Navas, Sara, et al.
Publicado: (2021)

Systematic Evaluation of Antigenic Stimulation in Chronic Lymphocytic Leukemia: Humoral Immunity as Biomarkers for Disease Evolution
por: Landeira-Viñuela, Alicia, et al.
Publicado: (2023)

Matrix Metalloproteinase-9 Is Involved in Chronic Lymphocytic Leukemia Cell Response to Fludarabine and Arsenic Trioxide
por: Amigo-Jiménez, Irene, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pl8cel4ir1g8gdtkcj0omfdegj